Now showing items 1-10 of 12
Allogeneic and Autologous Melanoma Vaccines: Where have we been and where are we going?
(2006-04)
The past three decades have seen substantial research on vaccines for the treatment of metastatic melanoma and the prevention of recurrence following resection. Despite their enormous promise, the actual results have been ...
Changes in Surgical Management Resulting from Case Review at a Breast Cancer Multidisciplinary Tumor Board
(American Cancer Society, 2006-08-21)
Surgical Therapy of Cutaneous Melanoma
(Elsevier, 2007)
For most solid tumors, therapy has evolved from surgery alone to a multidisciplinary approach. Malignant melanoma remains an exception, with surgery maintaining the principal role not only for treatment of the primary ...
Review of Evidence-Based Support for Pretreatment Imaging in Melanoma
(2009-03-02)
When making a new diagnosis of melanoma, clinicians often obtain imaging studies to rule out clinically occult distant disease.
These studies range from inexpensive tests, such as chest radiographs, to more expensive ...
The role of the surgeon in the management of melanoma.
(2006)
While multimodality therapy has become the standard for most solid tumors, the mainstay of therapy for melanoma remains surgical. This includes not only early stage disease, but advanced melanoma as well. The surgical ...
Is there a role for sentinel lymph node biopsy in the management of sarcoma?
(Elsevier, 2003)
Is there a role for sentinel lymph node (SLN) biopsy in the management of sarcoma? Sentinel node biopsy has dramatically
changed the management of melanoma and breast cancer, helping surgeons avoid radical lymphadenectomies ...
Is There A Role for Adjuvant High Dose Interferon in the Management of Melanoma
(Adis, 2003)
The knowledge that melanoma is susceptible to attack by the host’s immune system has resulted in the testing of a variety of immunotherapies. Interferon- α-2b, which has several anti-tumour mechanisms including an ...